Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CVNANASDAQ:WBANASDAQ:WBA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVNACarvana$319.87+4.4%$293.50$118.50▼$351.43$65.63B3.653.92 million shs7.94 million shsWBAWalgreens Boots Alliance$11.45+0.6%$11.21$8.08▼$13.25$9.85B0.7820.16 million shs10.96 million shsWBAWalgreens Boots Alliance$11.45+0.6%$11.21$8.08▼$13.25$9.85B0.7820.16 million shs10.96 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVNACarvana+4.28%-0.37%-0.03%+56.49%+152.72%WBAWalgreens Boots Alliance+0.62%+1.24%+2.32%+2.32%-26.88%WBAWalgreens Boots Alliance+0.62%+1.24%+2.32%+2.32%-26.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCVNACarvana3.4431 of 5 stars2.32.00.00.92.52.51.9WBAWalgreens Boots Alliance3.1176 of 5 stars0.95.00.02.32.53.30.6WBAWalgreens Boots Alliance3.1176 of 5 stars0.95.00.02.32.53.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVNACarvana 2.67Moderate Buy$284.18-11.16% DownsideWBAWalgreens Boots Alliance 1.83Reduce$10.59-7.50% DownsideWBAWalgreens Boots Alliance 1.83Reduce$10.59-7.50% DownsideCurrent Analyst Ratings BreakdownLatest WBA, CVNA, and WBA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/26/2025WBAWalgreens Boots AllianceMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight6/26/2025WBAWalgreens Boots AllianceUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral6/26/2025WBAWalgreens Boots AllianceMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight6/26/2025WBAWalgreens Boots AllianceUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral6/24/2025CVNACarvanaEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$295.00 ➝ $305.006/17/2025CVNACarvanaEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$290.00 ➝ $295.006/10/2025CVNACarvanaBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$325.00 ➝ $375.005/22/2025CVNACarvanaPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$315.00 ➝ $340.005/15/2025CVNACarvanaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$280.00 ➝ $290.005/8/2025CVNACarvanaWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/8/2025CVNACarvanaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$280.00 ➝ $325.00(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVNACarvana$13.67B5.01$2.23 per share143.38$6.47 per share49.44WBAWalgreens Boots Alliance$147.66B0.07$5.78 per share1.98$13.91 per share0.82WBAWalgreens Boots Alliance$147.66B0.07$5.78 per share1.98$13.91 per share0.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVNACarvana$210M$2.85112.2462.971.192.68%44.86%4.99%7/30/2025 (Estimated)WBAWalgreens Boots Alliance-$8.64B-$6.69N/A7.841.35-4.07%16.39%2.16%N/AWBAWalgreens Boots Alliance-$8.64B-$6.69N/A7.841.35-4.07%16.39%2.16%N/ALatest WBA, CVNA, and WBA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q3 2025WBAWalgreens Boots Alliance$0.34$0.38+$0.04-$0.20$36.72 billion$38.99 billion6/26/2025Q3 2025WBAWalgreens Boots Alliance$0.34$0.38+$0.04-$0.20$36.72 billion$38.99 billion5/7/2025Q1 2025CVNACarvana$0.75$1.51+$0.76$1.51$3.94 billion$4.23 billion4/8/2025Q2 2025WBAWalgreens Boots Alliance$0.53$0.63+$0.10-$3.30$37.90 billion$38.59 billion4/8/2025Q2 2025WBAWalgreens Boots Alliance$0.53$0.63+$0.10-$3.30$37.90 billion$38.59 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVNACarvanaN/AN/AN/AN/AN/AWBAWalgreens Boots AllianceN/AN/AN/AN/AN/AWBAWalgreens Boots AllianceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVNACarvana2.973.812.70WBAWalgreens Boots Alliance0.920.610.32WBAWalgreens Boots Alliance0.920.610.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVNACarvana56.71%WBAWalgreens Boots Alliance58.59%WBAWalgreens Boots Alliance58.59%Insider OwnershipCompanyInsider OwnershipCVNACarvana17.12%WBAWalgreens Boots Alliance17.50%WBAWalgreens Boots Alliance17.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVNACarvana17,400214.14 million177.48 millionOptionableWBAWalgreens Boots Alliance312,000865.56 million714.09 millionOptionableWBAWalgreens Boots Alliance312,000865.56 million714.09 millionOptionableWBA, CVNA, and WBA HeadlinesRecent News About These CompaniesWalgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Philip James Wealth Mangement LLC5 hours ago | marketbeat.comWealth Enhancement Advisory Services LLC Boosts Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)June 28 at 3:14 AM | marketbeat.comWBA Earnings: Walgreens Revenue Stuffs the Till, But Starves the ShareholderJune 27 at 12:52 AM | theglobeandmail.comWBA Walgreens Boots Alliance, Inc. - Seeking AlphaJune 27 at 12:52 AM | seekingalpha.comBoots marks 17th consecutive quarter of growth as online drives salesJune 27 at 12:52 AM | cosmeticsbusiness.comCWalgreens Tops Q3 Estimates Ahead of $10B Privatization DealJune 27 at 12:52 AM | msn.comWalgreens Boots Alliance says US front-end sales ‘weak’ in Q3 2025June 27 at 12:52 AM | msn.comWalgreens Sales Rise on Improvements in U.S. Healthcare Segment, Cost Cutting EffortsJune 27 at 11:42 PM | wsj.comWalgreens Stock Rises on Earnings. Pharmacy Chain Going Private This Year.June 27 at 6:32 PM | barrons.comWalgreens Boots Alliance, Inc. (NASDAQ:WBA) Position Trimmed by Quilter PlcJune 27 at 8:07 AM | marketbeat.comBoots defies market pressures with 17th straight quarter of growthJune 27 at 3:40 AM | retailgazette.co.ukRDecoding Walgreens Boots Alliance Inc (WBA): A Strategic SWOT InsightJune 26 at 12:48 AM | gurufocus.comWalgreens’ U.S. retail sales remain weak, but here’s why the stock is risingJune 26 at 10:39 PM | msn.comWalgreens Boots Alliance reports Q3 resultsJune 26 at 10:39 PM | drugstorenews.comDWalgreens Q3 earnings top expectations ahead of going privateJune 26 at 5:30 PM | uk.finance.yahoo.comWalgreens Sales Rise on Healthcare and Costs Cuts Ahead of Going PrivateJune 26 at 5:30 PM | msn.comLeerink Partners Reiterates a Hold Rating on Walgreens Boots Alliance (WBA)June 26 at 5:30 PM | msn.comWalgreens Boots Alliance third-quarter profit beats amid take-private dealJune 26 at 5:30 PM | finance.yahoo.comWalgreens beats Wall Street expectations ahead of sale to Sycamore PartnersJune 26 at 5:30 PM | chicagobusiness.comCWalgreens Outlook Improves As Buyout Faces Shareholder Vote Next MonthJune 26 at 5:30 PM | forbes.comWalgreens (NASDAQ:WBA) Exceeds Q2 ExpectationsJune 26 at 5:30 PM | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack Mode3 Hot Trades for Insiders, But Are They Good Buys for Investors?By Thomas Hughes | June 24, 2025View 3 Hot Trades for Insiders, But Are They Good Buys for Investors?WBA, CVNA, and WBA Company DescriptionsCarvana NYSE:CVNA$319.87 +13.39 (+4.37%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$319.02 -0.85 (-0.26%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Carvana Co., together with its subsidiaries, operates an e-commerce platform for buying and selling used cars in the United States. Its platform allows customers to research and identify a vehicle; inspect it using company's 360-degree vehicle imaging technology; obtain financing and warranty coverage; purchase the vehicle; and schedule delivery or pick-up from their desktop or mobile devices. The company also operates auction sites. The company was founded in 2012 and is based in Tempe, Arizona.Walgreens Boots Alliance NASDAQ:WBA$11.45 +0.07 (+0.62%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$11.42 -0.04 (-0.31%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.Walgreens Boots Alliance NASDAQ:WBA$11.45 +0.07 (+0.62%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$11.42 -0.04 (-0.31%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
